These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15020686)

  • 1. p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells.
    Cabodi S; Moro L; Baj G; Smeriglio M; Di Stefano P; Gippone S; Surico N; Silengo L; Turco E; Tarone G; Defilippi P
    J Cell Sci; 2004 Mar; 117(Pt 8):1603-11. PubMed ID: 15020686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.
    Chu I; Arnaout A; Loiseau S; Sun J; Seth A; McMahon C; Chun K; Hennessy B; Mills GB; Nawaz Z; Slingerland JM
    J Clin Invest; 2007 Aug; 117(8):2205-15. PubMed ID: 17627304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2.
    Walcher D; Babiak C; Poletek P; Rosenkranz S; Bach H; Betz S; Durst R; Grüb M; Hombach V; Strong J; Marx N
    Circ Res; 2006 Nov; 99(11):1181-7. PubMed ID: 17068290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
    Faivre E; Skildum A; Pierson-Mullany L; Lange CA
    Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
    Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
    Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
    van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
    Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Jun NH(2)-terminal kinase pathway in growth-promoting effect of the G protein-coupled receptor cholecystokinin B receptor: a protein kinase C/Src-dependent-mechanism.
    Dehez S; Bierkamp C; Kowalski-Chauvel A; Daulhac L; Escrieut C; Susini C; Pradayrol L; Fourmy D; Seva C
    Cell Growth Differ; 2002 Aug; 13(8):375-85. PubMed ID: 12193476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
    Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
    Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.
    Mawson A; Lai A; Carroll JS; Sergio CM; Mitchell CJ; Sarcevic B
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):161-73. PubMed ID: 15607540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
    Nakuci E; Mahner S; Direnzo J; ElShamy WM
    Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src-dependent association of Cas and p85 phosphatidylinositol 3'-kinase in v-crk-transformed cells.
    Riggins RB; DeBerry RM; Toosarvandani MD; Bouton AH
    Mol Cancer Res; 2003 Apr; 1(6):428-37. PubMed ID: 12692262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells.
    Hua KT; Way TD; Lin JK
    Mol Carcinog; 2006 Aug; 45(8):551-60. PubMed ID: 16637063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
    Balasenthil S; Barnes CJ; Rayala SK; Kumar R
    FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bidirectional "alpha(v)beta(3) integrin-ERK1/ERK2 MAPK" connection regulates the proliferation of breast cancer cells.
    Vellon L; Menendez JA; Lupu R
    Mol Carcinog; 2006 Oct; 45(10):795-804. PubMed ID: 16705745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
    Chen C; Chang YC; Liu CL; Liu TP; Chang KJ; Guo IC
    Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.